Option chain shows key data for Volvo's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Volvo.

Volvo (OTC:VLVLY) Stock, Option Chain

Volvo

Volvo AB drives prosperity through transport and infrastructure solutions, offering trucks, buses, construction equipment, power solutions for marine and industrial applications, financing, and services that increase the customers' uptime and productivity. Its segments are Trucks, Construction Equipment, Buses, Volvo Penta, and Group Functions & Other.

Volvo-Company

News

Tech

General

NVDA

VLVLY

Back in 2019, Nvidia partnered with Volvo Group to develop AI for self-driving trucks. 

Volvo Cars Expands Partnership With Nvidia For Advanced AI And Autonomous Driving

Volvo EX30

The new Volvo FH Electric is slated to hit the market in the second half of 2025.

Volvo Reveals Next-Gen Electric Heavy-Duty Truck With Up To 600 KM Range On A Single Charge

natural gas ai

Commodities

BLBD

CLNE

St. Louis Fed data shows all-time low for natural gas prices. Russia&#39;s pipeline closures caused spikes, but lower prices mean cheaper heating bills.

Natural Gas Has Never Been This Cheap: What Record Low Prices Mean For Heating Bills, Gas Vehicles

Volvo AB

<ul>
<li>FUJI SOFT Board unanimously resolved to recommend KKR's tender offer and oppose Bain Capital's proposal</li>
<li>Tender offer expected to launch middle of next week with price of 9,451 yen per share; shareholders and share option holders who tendered into first tender offer to be made whole if second tender offer succeeds</li>
</ul>
KKR, a leading global investment firm, today announced that in connection with its two-stage tender offer scheme (the "Tender Offer") for the common shares and share options of FUJI SOFT INCORPORATED (TSE stock code 9749; "FUJI SOFT") through FK Co., Ltd. (the "Offeror"), the Offeror, an entity owned by investment funds managed by KKR, will conduct the Second Tender Offer at a price of 9,451 yen per common share. KKR expects to commence the Second Tender Offer as soon as the middle of next week.

KKR Receives Support And Recommendation From FUJI SOFT For Second Tender Offer And Expects To Launch Tender Offer Next Week

Goldman Sachs analyst Vitor Tomita maintains Grupo Televisa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TV#NYSE">TV</a>) with a Buy and lowers the price target from $2.9 to $2.5.

Price Target

Analyst Ratings

Goldman Sachs Maintains Buy on Grupo Televisa, Lowers Price Target to $2.5

Terreno Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRNO#NYSE">TRNO</a>), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, sold the flex industrial portion of a seven-building Terreno Realty Corporation property located in Union City, California on November 14, 2024 for a sale price of approximately $13.0 million.
The property consists of two industrial flex buildings containing 37,000 square feet on 3.9 acres which are 100% leased to 20 tenants. The property was purchased by Terreno Realty Corporation on December 10, 2014 for approximately $5.1 million. The unleveraged internal rate of return generated by the investment was 18.8%.

Asset Sales

TRNO

Terreno Realty Corporation Sells Property In Union City, CA For $13M

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2024/11/14/final-trades-bitcoin-abbvie-and-baker-hughes.html">Halftime Report Final Trades</a>,&#8221; Jason Snipe of Odyssey Capital Advisors picked AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>).
On Monday, AbbVie said two trials investigating emraclidine as a once-daily, oral monotherapy treatment for adults with schizophrenia failed two Phase 2 trials. The studies did not meet their primary endpoint of showing a statistically significant improvement in the change from baseline in the Positive and Negative Syndrome Scale (PANSS) total score compared to the <a href="https://www.benzinga.com/general/biotech/24/11/41915173/abbvies-schizophrenia-failure-disappoints-but-analysts-show-confidence-in-immunology-portfolio">placebo group at week 6</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Stephen L. Weiss of Short Hills Capital Partners named Bitcoin as his <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41998395/bitcoin-ethereum-dogecoin-take-a-u-turn-as-jerome-powells-statements-dampen-rate-cut-expectations-analytics-firm-explains-why-btc-bull-market-has-not-yet-ended">final trade</a>.
Bitcoin prices pulled back as Federal Reserve Chair Jerome Powell&#8217;s remarks poured cold water on rate cut optimism. Bitcoin surged past the key $91,000 level on Thursday.
Joshua Brown of Ritholtz Wealth Management named Baker Hughes Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>).
On Oct. 22, Baker Hughes reported quarterly earnings of 67 cents per share which beat the analyst consensus estimate of 61 cents per share. The company reported quarterly sales of $6.91 billion. It missed the analyst consensus estimate of $7.22 billion. 
On Thursday, Citigroup analyst Scott Gruber maintained Baker Hughes with a Buy and raised the price target from $42 to $50.
Price Action:
<ul>
<li>At the time of writing, Bitcoin prices fell around 1.5%</li>
<li>AbbVie shares fell by 0.4% to settle at $169.63 during Thursday's session.</li>
<li>Baker Hughes gained 0.3% to close at $43.18 during Thursday's session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41971544/jim-cramer-recommends-microsoft-praises-american-water-works-for-being-consistent">Jim Cramer Recommends Microsoft, Praises American Water Works For Being &#8216;Consistent&#8217;</a></li>
</ul>
Image: Shutterstock

Long Ideas

Markets

Media

Trading Ideas

ABBV

AbbVie, Bitcoin And An Energy Stock On CNBC's 'Final Trades'

<a href="https://www.globenewswire.com/Tracker?data=PomMWl7Q68X2BTRC0CL0p5s4xRBZn71wIxRXWp39fmpV7yGoHGELGOweHf8o6ULXFuodz6A96pD8bAqGBxPtwA==">LogicMark, Inc.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) (the "Company"), a provider of personal emergency response systems (PERS), health communications devices, and technology for the growing care economy, today announced that the Company's board of directors has approved a reverse stock split of its common stock at a ratio of 1 post-split share for every 25 pre-split shares.
The Company's board of directors also approved a corresponding 1-for-25 reverse stock split ratio for its Series C preferred stock, which will occur simultaneously with the reverse stock split of its common stock. The reverse stock splits were approved at a Special Meeting of Stockholders, held on October 1, 2024, and the reverse stock split of the common stock is intended to bring the Company into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing on the Nasdaq Capital Market. The Company expects that the common stock will begin trading on a split-adjusted basis at the open of trading on Tuesday, November 19, 2024, under the new CUSIP number 67091J 602, and each of the reverse stock splits will be effective as of 5:00 p.m. Eastern Time on November 18, 2024, upon the filing of the applicable certificates with the Secretary of State of the State of Nevada.

Stock Split

LGMK

LogicMark, Inc. Announces 1-For-25 Reverse Stock Splits, Expects That The Common Stock Will Begin Trading On A Split-Adjusted Basis At The Open Of Trading On Tuesday, November 19, 2024, Under The New CUSIP Number, 67091J 602

Goldman Sachs analyst Brooke Roach maintains Tapestry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) with a Buy and raises the price target from $58 to $66.

Goldman Sachs Maintains Buy on Tapestry, Raises Price Target to $66

Macro Economic Events

Econ #s

Economics

USA Manufacturing Production (MoM) For October -0.5% Vs -0.5% Est.; -0.3% Prior

<ul>
<li>TSLA</li>
<li>ASTS</li>
<li>LUNR</li>
<li>NVDA</li>
<li>RKLB</li>
<li>SMCI</li>
<li>BABA</li>
<li>AI</li>
<li>AMAT</li>
<li>LOT</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AMAT

ASTS

BABA

LUNR

RKLB

SMCI

TSLA

Top 10 Trending Stocks On WallStreetBets As Of November 15, 2024 (Via Swaggy Stocks)

USA Industrial Production (MoM) For October -0.3% Vs -0.3% Est.; -0.5% Prior

Goldman Sachs analyst Caitlin Burrows maintains Tanger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKT#NYSE">SKT</a>) with a Neutral and raises the price target from $31 to $35.

Goldman Sachs Maintains Neutral on Tanger, Raises Price Target to $35

Compass CEO Robert Reffkin predicts Zillow, worth around $17 billion, will eventually become the nation's de facto Multiple Listing Service (MLS). This shift would <a href="https://www.benzinga.com/general/24/03/37919926/new-rule-change-could-be-worst-thing-ever-for-realtors-and-great-news-for-homebuyers-with-this-real">mark a significant change in real estate industry dynamics</a>. Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
<li>‘Beating the market through ethical real estate investing' —<a href="https://www.benzinga.com/money/invest-with-roots"> this platform aims to give tenants equity in the homes they live in while scoring 17.38% average annual returns for investors – here&#8217;s how to join with just $100</a></li>
</ul>
Initially reported by Inman, the prediction came during a discussion at the National Association of Realtors (NAR) annual conference last Friday amid ongoing debates over listing policies.
&#8220;I think if you were going to build an MLS today … I think it would be national,&#8221; Reffkin said during the &#8220;Future of the MLS&#8221; session. &#8220;There wouldn&#8217;t be 548. At some point, there will be a national MLS.&#8221;
His comments come as the industry grapples with changes to commission structures and listing practices following a recent legal decision. The traditional model of seller-paid commissions is evolving, with new rules eliminating commission information from MLS listings.
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
Reffkin praised Zillow&#8217;s business strategy while criticizing existing industry rules. &#8220;They were able to get access to all the listings and then charge referral fees on all the listings. It&#8217;s a great business model and those are rules that you&#8217;ve created, so they&#8217;re the winner,&#8221; he said.
Zillow&#8217;s Chief Industry Development Officer, Errol Samuelson, defended the current MLS system. &#8220;At its essence, the reason the MLS is so important is it is an unbiased, open, two-sided marketplace where there is equal access to information,&#8221; Samuelson said. &#8220;If it didn&#8217;t exist, we would feel obliged to invent it.&#8221;
Trending: Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
The debate intensifies as the industry adapts to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37798094/settlement-shake-up-nars-418m-agreement-reshapes-real-estate-dynamics">court-mandated changes in agent compensation</a>. Traditional practices of sellers paying both agents&#8217; commissions face scrutiny, with new requirements for explicit buyer-broker agreements.
&#8220;Any time we have the opportunity to have a conversation with the consumer about the value that we bring to the transaction … that&#8217;s a good thing,&#8221; NAR President Kevin Sears said, addressing the broader changes in commission structures, in an August USA Today report.
According to Stephen Brobeck of the Consumer Federation of America, the evolving landscape could reshape the industry within five years. &#8220;For consumers, things are not going to change much in the immediate future,&#8221; Brobeck told USA Today. &#8220;But it&#8217;s like a dam that&#8217;s springing a leak.&#8221;
See Also: This company is giving accredited investors an opportunity to invest in this $2 billion fund, <a href="https://www.benzinga.com/money/ignite-funding">with three decades in business they boast an impressive track record of double-digit returns.</a>
The new rule threatens smaller brokerages while potentially strengthening Zillow&#8217;s market position, supporting Reffkin&#8217;s prediction about the future of listing services in America.
Art Carter, CEO of California Regional MLS, highlighted the difficulty of managing industry changes across diverse stakeholder interests. &#8220;My top three brokers all have three different opinions on policy,&#8221; Carter said. The debate over listing policies and market structure continues as the industry searches for a balance between traditional practices and technological innovation in an increasingly digital real estate landscape.
Read Next:
<ul>
<li>Unlock the hidden potential of commercial real estate —<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Real Estate

$17 Billion Zillow To Become The MLS, Predicts Compass CEO In NAR Showdown

Federal employees are concerned over President-elect Donald Trump&#8217;s pick, Robert F. Kennedy Jr., to lead the Department of <a href="https://www.benzinga.com/government/regulations/24/11/41993115/trump-taps-rfk-jr-for-health-secretary-role-sends-5-vaccine-stocks-lower" target="_blank" rel="noreferrer noopener">Health and Human Services</a>.
What Happened: Employees within the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) are worried about Kennedy being in charge, given his critical stance on mainstream medical practices and vaccines.
Kennedy, who received Trump&#8217;s blessing to &#8220;<a href="https://www.benzinga.com/markets/cannabis/24/11/41828359/could-trumps-go-wild-on-health-invite-to-rfk-jr-drive-changes-for-cannabis-and-psychedelics">go wild on health</a>,&#8221; has stated intentions to overhaul various aspects of the federal health agencies. 
One plan is to slash the NIH&#8217;s 27 divisions to 15, according to NPR.
Joel Zinberg, a senior fellow at conservative think tanks, <a href="https://www.npr.org/2024/11/12/nx-s1-5183014/trump-election-2024-nih-rfk?utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=Scan%20Weds%202024-11-13&amp;utm_term=The%20Scan%20Bulletin" target="_blank" rel="noreferrer noopener">blamed</a> the pandemic for eroding public trust in agencies like the NIH and suggested that reforms might restore confidence.
See Also: <a href="https://www.benzinga.com/general/biotech/24/11/42006119/who-calls-vaccines-absolutely-critical-as-trumps-appointment-of-rfk-jr-pulls-pzifer-moderna-stocks-downhill">WHO Calls Vaccines &#8216;Absolutely Critical&#8217; As Trump&#8217;s Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill</a>
Why It Matters: Regarding the FDA, Kennedy will likely <a href="https://www.newsweek.com/rfk-jr-fda-departments-trump-presidency-1981671">eliminate</a> entire departments, such as the nutrition division. He also voiced plans <a href="https://www.benzinga.com/government/regulations/24/11/41936736/fda-commissioner-califf-candid-on-trumps-impact-we-just-dont-know-whats-going-to-happen" target="_blank" rel="noreferrer noopener">for broader reforms</a>.
Some employees are reportedly contemplating departure before Kennedy Jr. even arrives.
Former and current staff cited concerns stemming from Kennedy&#8217;s potential influence and previous positions as reasons for their apprehension.
One official <a href="https://www.nbcnews.com/health/health-news/fda-employees-consider-handle-rfk-jr-leaving-rcna180115" target="_blank" rel="noreferrer noopener">told</a> NBC News that despite initial concerns during Trump&#8217;s first term, there was &#8220;relatively little turnover,&#8221; with employees managing to align with new priorities, such as faster drug approval processes. 
However, the current atmosphere has a heightened sense of unease due to Kennedy&#8217;s potential involvement.
During an interview, FDA commissioner Robert Califf said he is &#8220;disappointed&#8221; about the election&#8217;s outcome. &#8220;I think we just don&#8217;t know what&#8217;s going to happen.&#8221;
While it remains to be seen what exact role Kennedy might hold, he has proposed an aggressive restructuring, including appointing new staff to replace 600 NIH employees.
Pharmaceutical Research and Manufacturers of America, a drug industry lobby group, <a target="_blank" href="https://phrma.org/resource-center/Topics/Leaders/PhRMA-Statement-on-HHS-Nomination" rel="noreferrer noopener">said</a>,&#8221; This industry is a crown jewel of the American economy, giving American patients more medicine choices than anywhere else in the world and supporting millions of high-paying, high-tech jobs around the country.
We want to work with the Trump administration to further strengthen our innovation ecosystem and improve health care for patients.&#8221;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/41987123/blood-cancer-focused-blueprint-medicines-could-be-attractive-target-for-partnerships-analyst-initiates-with-around-30-upside" target="_blank" rel="noreferrer noopener">Blood Cancer-Focused Blueprint Medicines Could Be &#8216;Attractive Target For Partnerships&#8217;: Analyst</a></li>
</ul>
Image: Shutterstock

Biotech

Government

Health Care

Politics

Robert Kennedy Poised To Lead Health And Human Services: Why FDA, NIH Officials Are Nervous

Canaccord Genuity analyst Austin Moeller maintains Intuitive Machines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) with a Buy and raises the price target from $11 to $12.5.

Canaccord Genuity Maintains Buy on Intuitive Machines, Raises Price Target to $12.5

CNS Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) by 108.33 percent. This is a 99.54 percent increase over losses of $(54.14) per share from the same period last year.

Earnings

CNSP

CNS Pharmaceuticals Q3 EPS $(0.25) Misses $(0.12) Estimate

Goldman Sachs analyst Will Nance maintains Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) with a Neutral and raises the price target from $23.5 to $33.

Goldman Sachs Maintains Neutral on Paymentus Holdings, Raises Price Target to $33

On November 15, 2024, in connection with a one-for-two reverse stock split (the "Reverse Stock Split") of the common stock, $0.01 par value per share (the "Common Stock") of Wheeler Real Estate Investment Trust, Inc. (the "Company"), to be effective on November 18, 2024, the Company filed two Articles of Amendment to its charter with the State Department of Assessments and Taxation of Maryland that provide for:
 &nbsp;
i.a one-for-two Reverse Stock Split of the Common Stock, to be effective at 5:00 p.m. Eastern Time (the&nbsp;"Effective Time") on November 18, 2024 (the "First Amendment"); and
ii.the par value of the Common Stock to be decreased from $0.02 per share (as a result of the one-for-two Reverse Stock Split) to $0.01 per share, to be effective at 5:01 p.m. Eastern Time on November 18, 2024 (the "Second Amendment").
 &nbsp;
Pursuant to the First Amendment, no fractional shares will be issued in connection with the Reverse Stock Split; rather, stockholders who would have otherwise been issued a fractional share of the Common Stock as a result of the Reverse Stock Split will instead receive a cash payment in lieu of such fractional share in an amount equal to the applicable fraction multiplied by the closing price of the Company's Common Stock on The Nasdaq Capital Market on November 18, 2024 (as adjusted for the Reverse Stock Split), without any interest.
 &nbsp;
The foregoing descriptions of the amendments to the Company's charter do not purport to be complete and are qualified in their entirety by reference to each amendment, copies of which are filed as Exhibit 3.1 and Exhibit 3.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.
 &nbsp;
Effect of Reverse Stock Split on Common Stock
 &nbsp;
At the market open on November 19, 2024 (the first business day after the Effective Time), the Common Stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market under a new CUSIP number (963025846).
 &nbsp;
The Reverse Stock Split will apply to all of the outstanding shares of Common Stock as of the Effective Time, with a corresponding adjustment to the outstanding partnership units of the Company's operating partnership, Wheeler REIT, L.P. It therefore will not affect any particular stockholder's relative ownership percentage of shares of Common Stock, except for de minimis changes resulting from the payment of cash in lieu of fractional shares. The Reverse Stock Split will also not affect the relative voting or other rights that accompany the shares of Common Stock, except to the extent that it results from a stockholder receiving cash in lieu of fractional shares. There will be no change to the number of authorized shares of the Common Stock as a result of the Reverse Stock Split. The Company's trading symbol will remain unchanged, but the CUSIP number for the Company's registered Common Stock will be changed to 963025846.
 &nbsp;
In connection with the Reverse Stock Split, adjustments will be made to the number of shares of Common Stock issuable upon conversion of the Company's convertible securities.
 &nbsp;

WHLR

Wheeler Real Estate Investment Trust Announces 1-For-2 Reverse Stock Split Effective November 18; Will Trade Under New CUSIP Number, 963025846

Canaccord Genuity analyst George Gianarikas maintains Dragonfly Energy Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) with a Buy and lowers the price target from $1.5 to $1.25.

DFLI

Canaccord Genuity Maintains Buy on Dragonfly Energy Hldgs, Lowers Price Target to $1.25

Canaccord Genuity analyst Kyle Mikson maintains Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) with a Buy and lowers the price target from $6 to $3.5.

AKYA

Canaccord Genuity Maintains Buy on Akoya Biosciences, Lowers Price Target to $3.5

Goldman Sachs analyst Tito Labarta maintains PagSeguro Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAGS#NYSE">PAGS</a>) with a Buy and lowers the price target from $14 to $12.

PAGS

Goldman Sachs Maintains Buy on PagSeguro Digital, Lowers Price Target to $12

Vertically integrated cannabis operator Acreage Holdings, Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRG#CSE">ACRG</a>, ACRG.B.U)) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ACRHF#OTCQX">ACRHF</a>, ACRDF)) reported its financial results Thursday for the third quarter ended Sept. 30, 2024.
"In the third quarter, we continued to focus on re-accelerating growth across our core states, including Connecticut, Illinois, and New Jersey, while also executing on the highly anticipated launch of non-medical sales in Ohio,&#8221; said CEO Dennis Curran. &#8220;With our strengthened financial position, we have bolstered our capacity to pursue opportunities in these markets as they continue to mature, which is expected to play a pivotal role in driving both revenue generation and improvements in Adjusted EBITDA as we close out 2024."
<h3 class="wp-block-heading">Q3 2024 Financial Highlights</h3>
<ul>
<li>Consolidated revenue totaled $39.6 million, representing a 30% decrease YoY.</li>
<li>Gross margin was 35%, down from 38% in the third quarter of 2023.</li>
<li>Total operating expenses amounted to $22.6 million, down from $24 million in the same period of last year.</li>
<li>Net loss was $22.2 million, up from a loss of $7.9 million in the previous year's quarter.</li>
<li>Adjusted EBITDA came in positive at $0.6 million, representing a drop from $6.6 million in the third quarter of 2023.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40398055/acreage-holdings-q2-revenue-drops-invests-in-ohio-growth-as-canopy-acquisition-nears">Acreage Holdings Q2 Revenue Drops, Invests In Ohio Growth As Canopy Acquisition Nears</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Q3 2024 Operational Highlights</h3>
<ul>
<li>Launched recreational cannabis sales in Ohio at five Botanist retail locations, contributing to 38% of third-quarter revenue in the state.</li>
<li>Debut Superflux flower in Illinois, with strong wholesale penetration.</li>
<li>Achieved record wholesale revenue performance in New York.</li>
<li>Secured a $65 million credit agreement, resulting in the repayment of prior debts.</li>
<li>Gained green light for a new dispensary in Collingswood, New Jersey.</li>
</ul>
<h3 class="wp-block-heading">Outlook</h3>
Canopy USA, Canopy Growth Corporation&#8216;s (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WEED#TSX">WEED</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) strategy to consolidate its U.S.-based assets &#8211; is set to acquire Acreage in 2025.
Curran emphasized efforts to boost growth in key markets like Connecticut, Illinois, and New Jersey while leveraging Acreage&#8217;s strong medical reputation in Ohio.
<h3 class="wp-block-heading">ACRHF Price Action</h3>
Acreage's shares traded 4.29% lower at $0.134 per share after the market close on Thursday afternoon.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40742561/ohios-cannabis-sales-reach-44m-as-new-customers-just-keep-coming-and-demand-is-not-slowing">Ohio&#8217;s Cannabis Sales Reach $44M As New Customers Just Keep Coming And Demand Is Not Slowing</a></li>
</ul>

Cannabis

ACRDF

ACRHF

CSE:ACRG

TSX:WEED

WEED

Canopy Growth Acquisition Target Acreage Reports 30% YoY Decline In Q3, Record Cannabis Wholesale Revenue In NY

Volvo: Why I Am Mostly Out Of This Industrial, And Have Been For Some Time

UBS upgraded Volvo (VLVLY) to Neutral from Sell with a price target of SEK 273, up from SEK 263. The firm says concerns over the truck downcycle ar...

Volvo upgraded to Neutral from Sell at UBS

Barclays analyst Erwann Dagorne maintained a Hold rating on Volvo AB (0HTP – Research Report) on October 24 and set a price target of SEK280.00. Th...

Barclays Keeps Their Hold Rating on Volvo AB (0HTP)

As announced in May this year, Volvo (VLVLY) Group and Daimler Truck intend to create a joint venture to develop a common software-defined vehicle ...

Volvo, Daimler Truck sign binding agreement for joint venture

Volvo Group and Daimler join hands for software-defined vehicle platform

Kepler Capital analyst Mats Liss maintained a Buy rating on Volvo AB (0HTP – Research Report) on November 5 and set a price target of SEK310.00. Th...

Volvo AB (0HTP) Gets a Buy from Kepler Capital

Luminar Technologies reports mixed Q3 results, disclosed two new business deals

CNH: Weathering A Storm With 40% EPS Drop

J.P. Morgan analyst Jose Asumendi maintained a Hold rating on Volvo AB (0HTP – Research Report) today and set a price target of SEK290.00. The comp...

J.P. Morgan Reaffirms Their Hold Rating on Volvo AB (0HTP)

In a report released on November 13, Mats Liss from Kepler Capital maintained a Buy rating on Volvo AB (0HTP – Research Report), with a price targe...

Comments

Volvo

Volvo (VLVLY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga